Donna Ambrosino
Directeur/Membre du Conseil chez CLOVER BIOPHARMACEUTICALS, LTD.
Fortune : 7 039 $ au 30/04/2024
Postes actifs de Donna Ambrosino
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Directeur/Membre du Conseil | 17/06/2022 | - |
Historique de carrière de Donna Ambrosino
Anciens postes connus de Donna Ambrosino
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| VISTERRA INC | Directeur Technique/Scientifique/R&D | 01/01/2012 | 01/01/2014 |
| Harvard Medical School | Corporate Officer/Principal | - | - |
Formation de Donna Ambrosino
| Dartmouth Medical School | Doctorate Degree |
| Harvard University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Chine | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Visterra, Inc.
 Visterra, Inc. Pharmaceuticals: MajorHealth Technology Visterra, Inc. Is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of antibody-based therapies for kidney diseases, and other chronic diseases. It focuses on its research technology platform, HIEROTOPE technology. The company was founded by Alan L. Crane, Kevin J. Bitterman and Ram Sasisekharan on December 20, 2007 and is headquartered in Waltham, MA. | Health Technology |
- Bourse
- Insiders
- Donna Ambrosino
- Expérience
